Inventor · disambiguated record
Rolf A. Brekken
Also filed as: BREKKEN ROLF · BREKKEN ROLF A
19 granted patents·4 pending applications·2,249 citations·filing 1999–2021
97Inventor score
Top patents by PatentIndex Score
23 records- 0199US6703020B1Antibody conjugate methods for selectively inhibiting VEGFUNIV TEXAS·Filed 2000·Granted Mar 9, 2004·296 cites·49 claims
- 0299US6524583B1Antibody methods for selectively inhibiting VEGFUNIV TEXAS·Filed 2000·Granted Feb 25, 2003·215 cites·40 claims
- 0399US6342221B1Antibody conjugate compositions for selectively inhibiting VEGFUNIV TEXAS·Filed 2000·Granted Jan 29, 2002·354 cites·68 claims
- 0499US6342219B1Antibody compositions for selectively inhibiting VEGFUNIV TEXAS·Filed 2000·Granted Jan 29, 2002·651 cites·50 claims
- 0598US6783760B1Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipidsUNIV TEXAS·Filed 2001·Granted Aug 31, 2004·87 cites·54 claims
- 0698US6676941B2Antibody conjugate formulations for selectively inhibiting VEGFUNIV TEXAS·Filed 2001·Granted Jan 13, 2004·144 cites·68 claims
- 0798US6416758B1Antibody conjugate kits for selectively inhibiting VEGFUNIV TEXAS·Filed 2000·Granted Jul 9, 2002·153 cites·50 claims
- 0897US7056509B2Antibody methods for selectively inhibiting VEGFUNIV TEXAS·Filed 2003·Granted Jun 6, 2006·77 cites·22 claims
- 0996US6887468B1Antibody kits for selectively inhibiting VEGFUNIV TEXAS·Filed 2000·Granted May 3, 2005·70 cites·55 claims
- 1094US6818213B1Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipidsUNIV TEXAS·Filed 1999·Granted Nov 16, 2004·95 cites·64 claims
- 1192US7067109B1Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipidsUNIV TEXAS·Filed 1999·Granted Jun 27, 2006·57 cites·35 claims
- 1291US7790860B2Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipidsUNIV TEXAS·Filed 2009·Granted Sep 7, 2010·15 cites·15 claims
- 1390US8709430B2Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipidsTHORPE PHILIP E·Filed 2005·Granted Apr 29, 2014·5 cites·32 claims
- 1488US7550141B2Methods for imaging tumor vasculature using conjugates that bind to aminophospholipidsUNIV TEXAS·Filed 2004·Granted Jun 23, 2009·12 cites·20 claims
- 1585US9233162B2High affinity VEGF-receptor antagonistsKODADEK THOMAS·Filed 2010·Granted Jan 12, 2016·5 cites·38 claims
- 1685US8334239B2High affinity VEGF-receptor antagonistsKODADEK THOMAS·Filed 2008·Granted Dec 18, 2012·6 cites·19 claims
- 1782US9986723B2Screen and use of therapeutics for pancreatic ductal adenocarcinomaUNIV TEXAS·Filed 2015·Granted Jun 5, 2018·4 cites·3 claims
- 1875US10370360B2Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereofUNIV TEXAS·Filed 2015·Granted Aug 6, 2019·3 cites·19 claims
- 1964US2014205544A1Cancer Treatment Comprising Therapeutics That Bind To PhosphatidylserineUNIV TEXAS·Filed 2014·Application pending·0 cites
- 2063US2016199509A1Cancer Treatment Comprising Therapeutics That Bind to PhosphatidylserineUNIV TEXAS·Filed 2016·Application pending·0 cites
- 2160US2005123537A1Antibody conjugate methods for selectively inhibiting VEGFUNIV TEXAS·Filed 2003·Application pending·0 cites
- 2252US10849875B2Cancer specific lipid targeted peptidomimeticsUNIV HOUSTON SYSTEM·Filed 2016·Granted Dec 1, 2020·0 cites·11 claims
- 2349US2023151100A1Method of Selecting Patients for Treatment with a Combination of an AXL Inhibitor and an Immune Checkpoint ModulatorBERGENBIO ASA·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rolf A. Brekken files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →